CYFRA 21-1 Human Antigen

<strong>CYFRA 21-1 Human Antigen</strong>_x000D_ <strong>Catalog number:</strong> B2010543_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> marker for the detection of tumor cells in lymph nodes and other locations_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> cytokeratin 19 fragment, Cytokeratin 19, Keratin 19, CK-19, K19, Type I Cytoskeletal 19, Cyfra 21-1, Keratin, type I cytoskeletal 19_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Cho HY, Kyung MS. CYFRA 21-1 and Placental Growth Factor as Screening Markers_x000D_ for Endometriosis. Med Sci Monit. 2019 Feb 9;25:1087-1092._x000D_ _x000D_ 2: Hyun JW, Shin HS, Kim SH, Kong SY, Yoo H, Gwak HS, Kim HJ. CYFRA 21-1 levels_x000D_ in cerebrospinal fluid as a putative therapeutic monitoring biomarker for_x000D_ patients with leptomeningeal carcinomatosis: A pilot study. Cancer Biomark._x000D_ 2020;28(1):81-89._x000D_ _x000D_ 3: Rudhart SA, Schultz JD, Gehrt F, Pavel FL, Birk R, Hoch M, Stuck BA, Hoch S._x000D_ CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous_x000D_ squamous cell carcinoma? Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3467-3475._x000D_ _x000D_ 4: Rudhart SA, Gehrt F, Birk R, Schultz JD, Stankovic P, Georgiew R, Wilhelm T,_x000D_ Stuck BA, Hoch S. Clinical relevance of CYFRA 21-1 as a tumour marker in_x000D_ patients with oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol._x000D_ 2020 Sep;277(9):2561-2571._x000D_ _x000D_ 5: Shirasu H, Ono A, Omae K, Nakashima K, Omori S, Wakuda K, Kenmotsu H, Naito_x000D_ T, Murakami H, Endo M, Nakajima T, Takahashi T. CYFRA 21-1 predicts the efficacy_x000D_ of nivolumab in patients with advanced lung adenocarcinoma. Tumour Biol. 2018_x000D_ Feb;40(2):1010428318760420._x000D_ _x000D_ 6: AlAli AM, Walsh T, Maranzano M. CYFRA 21-1 and MMP-9 as salivary biomarkers_x000D_ for the detection of oral squamous cell carcinoma: a systematic review of_x000D_ diagnostic test accuracy. Int J Oral Maxillofac Surg. 2020 Aug;49(8):973-983._x000D_ _x000D_ 7: Matuszczak M, Salagierski M. Diagnostic and Prognostic Potential of_x000D_ Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers. Int J Mol_x000D_ Sci. 2020 May 9;21(9):3360._x000D_ _x000D_ 8: Huang YL, Chen J, Yan W, Zang D, Qin Q, Deng AM. Diagnostic accuracy of_x000D_ cytokeratin-19 fragment (CYFRA 21-1) for bladder cancer: a systematic review and_x000D_ meta-analysis. Tumour Biol. 2015 May;36(5):3137-45._x000D_ _x000D_ 9: Vercauteren IM, Verleden SE, McDonough JE, Vandermeulen E, Ruttens D,_x000D_ Lammertyn EJ, Bellon H, De Dycker E, Dooms C, Yserbyt J, Verleden GM,_x000D_ Vanaudenaerde BM, Wuyts WA. CYFRA 21.1 in bronchoalveolar lavage of idiopathic_x000D_ pulmonary fibrosis patients. Exp Lung Res. 2015;41(8):459-65._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/31218849/">10: Lin Q, Chen XY, Liu WF, Zhu PW, Shi WQ, Li B, Yuan Q, Min YL, Liu JM, Shao_x000D_ Y. Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular_x000D_ metastasis in patients with metastatic lung cancer. Cancer Med. 2020_x000D_ Feb;9(4):1279-1286. </a>_x000D_ _x000D_ <strong>Products Related to CYFRA 21-1 Human Antigen</strong><a href="https://moleculardepot.com/product-category/Proteins/">: Proteins</a>